SCHEMBL13438176

SCHEMBL13438176

CC(=O)O/N=C(\C(=O)c1ccc(CO)c2ccccc12)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ELANE P08246 1/20 0.34
▸ ACE2 Q9BYF1 3/20 0.33
▸ AKR1C4 P17516 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ AKR1C1 Q04828 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NLRP3 Q96P20 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CES2 O00748 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ NPC1 O15118 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87769 0.82 CDC25B (0.49) MAPK1MAPTKMT2ACYP2C9HIF1A
SCHEMBL9897113 0.77 CES2 (0.50) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL12328537 0.77 CES2 (0.50) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL9897115 0.77 CES2 (0.50) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL2045675 0.75 CYP2C19 (0.48) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL2045676 0.75 CYP2C19 (0.48) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL11399000 0.72 CYP2C19 (0.46) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL25314654 0.71 CYP2C19 (0.58) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL11521468 0.71 CYP2C19 (0.58) MAPK1MAPTELANEPKML3MBTL1
SCHEMBL14194047 0.70 KDM4E (0.44) MAPTACE2AKR1C4AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696257-B2 Oxime ester compound and photopolymerization initiator containing such compound ADEKA CORPORATION (JP) 2010-04-13 — — US disclosed
US-20070270522-A1 Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound ADEKA CORPORATION (JP) 2007-11-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270522-A1 Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound CBR3, CBR1, SCLY MAPK1 2637/4885MAPT 4262/4885ELANE 3086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback